This energy name is outperforming and is still too cheap to ignore, says Jefferies

Jefferies upgraded Devon Energy to buy from hold and raised its price target to $62 from $53, implying 37% upside from Thursday's close. The firm argues Devon is too cheap at 8.28x forward earnings and should benefit from the recently closed Coterra merger, which is expected to generate about $1 billion in synergies and support debt reduction and asset sales. Despite weaker oil prices, the analyst sees multiple catalysts for relative outperformance.

Analysis

DVN’s setup is less about the next $5 move in crude and more about a visible self-help catalyst stack that can re-rate the equity even if the commodity tape softens. That matters because the market typically underwrites upstream cash flows to spot oil, but assigns a lower discount to balance-sheet repair, synergy capture, and asset rationalization when those are company-specific and near-term. In other words, Jefferies is implicitly arguing DVN is evolving from a beta trade into a cleaner FCF conversion story.

The second-order winner is likely DVN’s equity base, while the loser is the low-quality shale complex where balance-sheet leverage and lack of identifiable catalysts will look even worse on a relative basis. If DVN can convert divestitures into debt reduction, the stock can compound on a multiple expansion rather than just earnings growth, which is especially powerful in a 8x-ish forward multiple name. CTRA is not the direct economic beneficiary here, but its strategic value as an accretive asset owner remains highlighted; the market may start underwriting similar takeout optionality across mid-cap E&Ps.

The main risk is timing: merger integration and asset sale execution rarely hit the tape in a straight line, and the stock can de-rate quickly if oil weakens faster than synergy headlines arrive. A 10-15% pullback in front-month crude would likely test the thesis over days to weeks, while the real validation window is 1-2 quarters as cost synergies and non-core monetizations become visible. If those actions slip, the stock reverts to being a commodity proxy, and the current valuation support becomes less durable.

Consensus looks directionally right but may still be underestimating the convexity of a de-levering story in a cash-rich E&P. The market often pays up only after the first post-close evidence point; that creates a window where upside can be captured before the rerating is fully priced. The risk/reward is asymmetric because downside is partly cushioned by the low multiple, while upside can come from both multiple expansion and incremental FCF per share improvement.

Key Decisions for Investors

• Go long DVN on 1-3 month horizon with a target toward the new analyst PT area; risk/reward is attractive if oil stays range-bound because the stock can rerate on deal-close integration and divestiture headlines rather than crude alone.
• Buy DVN call spreads expiring in 60-120 days to express catalyst upside with defined downside; structure around a modest move higher in the stock as synergy capture and asset-sale optionality come into focus.
• Pair long DVN / short a weaker, higher-leverage shale peer basket over the next 1-2 quarters to isolate self-help vs commodity beta; the trade works best if oil drifts lower while company-specific catalysts persist.
• If already long energy beta, rotate part of exposure from broad XLE into DVN to increase idiosyncratic catalyst exposure; this improves expected return if the front of the curve fades.
• Take profits or tighten stops if DVN fails to hold relative strength after the first post-close update; the thesis weakens materially if management cannot show early progress on debt reduction or non-core monetization.